U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 9

1.
Figure 1

Figure 1. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

Chemical structures of the agents used in this study. The anionic forms of the compounds are shown. The sulphonylurea moiety and benzamide group of glibenclamide are indicated.

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.
2.
Figure 4

Figure 4. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

Mitiglinide inhibits CFTR Cl currents. (a) Time-course of CFTR Cl current in an excised inside-out membrane patch. ATP (0.3 mM), PKA (75 nM), and mitiglinide (50–500 μM) were present in the intracellular solution during the times indicated by the bars; other details as in . (b) Hill plot of the effect of mitiglinide concentration on CFTR Cl currents. Data are means±s.e.mean; n=4–5 observations at each concentration. The continuous line is the fit of a first-order regression to the data. Other details as in (a).

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.
3.
Figure 7

Figure 7. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

Effect of mitiglinide on the single-channel activity of CFTR. (a) Representative recordings show the effect of mitiglinide (250 μM) on the activity of a single CFTR Cl channel. ATP (0.3 mM) and PKA (75 nM) were continuously present in the intracellular solution; voltage was −50 mV. Scale bar, 2 s and 200 ms for prolonged and expanded recordings, respectively. (b) and (c) Effect of mitiglinide (250 μM) on i and Po, respectively. Columns and error bars indicate means±s.e.mean (n=6) for each concentration. Mitiglinide (250 μM) was without effect on i (n=6; P>0.05), but decreased Po to 41±5% (n=6; P<0.05). Other details as in (a).

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.
4.
Figure 6

Figure 6. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

Effect of repaglinide on the single-channel activity of CFTR. (a) Representative recordings show the effect of repaglinide (50 μM) on the activity of a single CFTR Cl channel. ATP (0.3 mM) and PKA (75 nM) were continuously present in the intracellular solution; voltage was −50 mV. Scale bar, 2 s and 200 ms for prolonged and expanded recordings, respectively. (b) and (c) Effect of repaglinide (50 μM) on i and Po, respectively. Columns and error bars indicate means±s.e.mean (n=6) for each concentration. Repaglinide (50 μM) decreased i to 91±2% of the control value (n=6; P=0.005), but was without effect on Po (n=6; P>0.05). Other details as in (a).

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.
5.
Figure 9

Figure 9. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

Voltage-dependent inhibition of CFTR Cl channels by meglitinide and mitiglinide. (a) and (b) Relationships between Po and voltage in the absence (filled symbols) and presence (open symbols) of meglitinide (250 μM) and mitiglinide (250 μM) when the membrane patch was bathed in symmetrical 147 mM Cl solutions. Data points are means±s.e.mean (meglitinide: n=3–5; mitiglinide: n=3–4) at each voltage. (c) Relationship between KD and voltage for the data shown in (a) and (b). KD values were calculated as described in Results and the continuous lines are the fit of first-order regressions to the data. For comparison, the dotted line shows the relationship between KD and voltage for glibenclamide under similar experimental conditions. Data for glibenclamide are from .

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.
6.
Figure 3

Figure 3. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

When compared to glibenclamide, repaglinide only weakly inhibits CFTR Cl currents. (a) Time-course of CFTR Cl current in an excised inside-out membrane patch. ATP (1.0 mM), PKA (75 nM), repaglinide (50 μM), and glibenclamide (50 μM) were present in the intracellular solution during the times indicated by the bars; other details as in . (b) Comparison of the effects of repaglinide (50 μM) and glibenclamide (50 μM) on CFTR Cl currents. Columns and error bars indicate means±s.e.mean (n=5) for each concentration. Values represent the average current recorded during an intervention normalised to that measured under control conditions at the start of the experiment. Repaglinide (50 μM) reduced CFTR Cl current to 87±3% of control (n=5; P<0.05), whereas glibenclamide (50 μM) reduced CFTR Cl current to 37±4% of control (n=5; P<0.001). Other details as in (a). In the presence of both glibenclamide (50 μM) and repaglinide (50 μM) CFTR Cl currents were reduced to 37±3% of control (n=5), a value not significantly different from that observed in the presence of glibenclamide (50 μM; n=5; P>0.05).

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.
7.
Figure 2

Figure 2. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

Meglitinide inhibits CFTR Cl currents. (a) Time-course of CFTR Cl current in an excised inside-out membrane patch. ATP (0.3 mM), PKA (75 nM), and meglitinide (50–500 μM) were present in the intracellular solution during the times indicated by the bars. Voltage was −50 mV, and there was a large Cl concentration gradient across the membrane patch (internal [Cl]=147 mM; external [Cl]=10 mM). Each point is the average current for a 4 s period and no data were collected while solutions were changed. For the purpose of illustration, the time-course has been inverted so that an upward deflection represents an inward current. (b) Hill plot of the effect of meglitinide concentration on CFTR Cl currents. Data are means±s.e.mean; n=3–6 observations at each concentration. The continuous line is the fit of a first-order regression to the data. Other details as in (a).

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.
8.
Figure 8

Figure 8. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

Open and closed time histograms of single CFTR Cl channels inhibited by meglitinide and mitiglinide. (a) and (b) Effect of meglitinide and mitiglinide on the open (top) and closed (bottom) time histograms of CFTR, respectively. Data are from experiments in which the membrane patch contained only one active channel, studied in the absence and presence of either meglitinide (250 μM) or mitiglinide (250 μM); ATP (0.3 mM) and PKA (75 nM) were present throughout and voltage was −50 mV. For open time histograms, the continuous line is the fit of either a one- (control, meglitinide) or a two- (mitiglinide) component exponential function. For closed time histograms, the continuous line is the fit of either a two- (control, meglitinide) or a three- (mitiglinide) component exponential function. Dashed lines show the individual components of the exponential functions. Logarithmic x-axes with 10 bins decade−1 were used for both open and closed time histograms. Other details as in .

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.
9.
Figure 5

Figure 5. From: Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl− channels by non-sulphonylurea hypoglycaemic agents.

Effect of meglitinide on the single-channel activity of CFTR. (a) Representative recordings show the effect of meglitinide (250 μM) on the activity of a single CFTR Cl channel. ATP (0.3 mM) and PKA (75 nM) were continuously present in the intracellular solution. Voltage was −50 mV, and there was a large Cl concentration gradient across the membrane patch (internal [Cl]=147 mM; external [Cl]=10 mM). Scale bar, 2 s and 200 ms for prolonged and expanded recordings, respectively. Dashed lines indicate the closed channel state and downward deflections correspond to channel openings. For the purpose of illustration, records were filtered at 500 Hz and digitised at 1 kHz. (b) and (c) Effect of meglitinide (250 μM) on i and Po, respectively. Columns and error bars indicate means±s.e.mean (n=7) for each concentration. Meglitinide (250 μM) decreased i to 92±1% of the control value (n=7; P<0.001) and Po to 42±3% of the control value (n=7; P<0.001). Other details as in (a).

Z Cai, et al. Br J Pharmacol. 1999 Sep;128(1):108-118.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center